跳至主要内容
临床试验/NCT01745718
NCT01745718撤回不适用

Targeted Biopsies and the Role of Cytological Imprints for Diagnosis of Prostate Cancer

Oslo University Hospital2 个研究点 分布在 1 个国家开始时间: 2012年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
2
主要终点
The rate of positive and negative cytological imprints, e.g presence of malignant cells or not.

研究概览

简要总结

The investigators will evaluate the accuracy of performing cytological imprints of targeted biopsies when diagnosing prostate cancer.

It is useful to know whether the biopsy is cancer or not, in order to know when to stop sampling and when to continue.

The strategy is used in other types of cancer, e.g lung, breast etc

详细描述

Background:

When substituting a random biopsy procedure with a few targeted biopsies, it is of outmost importance to know immediately if the biopsy is positive or not. A recent study has demonstrated a high sensitivity and specificity of imprint cytology of random biopsies.

Aim:

The correlation between cytological imprints and histology of targeted prostate biopsies

Material&Method:

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

性别
Male
接受健康志愿者

入选标准

  • Prostate specific antigene (PSA) 4-20ng/ml, and/or abnormal digital rectal examination
  • No previous prostate biopsies
  • Positive MRI
  • Signed letter of informed concent

排除标准

  • Contraindications to MRI
  • Previous prostate biopsies

结局指标

主要结局

The rate of positive and negative cytological imprints, e.g presence of malignant cells or not.

时间窗: 15 months

The cytological imprints will be compared to the histology of targeted biopsies (defined as gold standard). Measure of agreement, sensitivity and specificity will be calculated.

次要结局

  • Interobserver variability(15 months)

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验